Developer docs
API playgroundTry for free, no card

Search company profiles

CHES Foundation

Full company profile

uuid02lx9lw

Namestring
CHES Foundation
Legal namestring
CHES Foundation, Inc.
Company typeenum
Private
Founded yearint
2009
Descriptiontext

CHES Foundation is a 501(c)(3) non-profit organization founded in 2009 and headquartered in Noblesville, Indiana, that delivers education, peer support, and advocacy programs to the rare bleeding disorder community in the United States. The organization concentrates on three underserved populations: individuals with inhibitors (antibodies that neutralize standard clotting factor treatment), patients with ultra-rare bleeding disorders (including Glanzmann Thrombasthenia and rare factor deficiencies), and women with bleeding disorders. Its core program portfolio includes InhibitCon (a national inhibitor conference with caregiver, adult, and teen tracks), After The Shock (a family camp), Leverage (an adventure-based adult program delivered with GutMonkey), LadyBugs (a women's conference), One Drop (an ultra-rare disorders program), and awareness campaigns SHEmophilia and Hermanas de Sangre.

The organization's technology stack is intentionally lean and community-focused: a Squarespace-hosted website at ches.education, JotForm for application processing, Zoom for virtual programs, and active social media presence across Facebook, Instagram, LinkedIn, and YouTube. CHES produces proprietary content assets including the LifeLines for Health newsletter (described as the only worldwide publication dedicated to inhibitor topics) and The Bleeding Edge podcast (a narrative series on Glanzmann Thrombasthenia). Programs are delivered through a hybrid model combining national in-person events at hotels and camps with virtual webinars, supported by an application-based screening process and travel reimbursement for participants.

Revenue is generated primarily through pharmaceutical manufacturer grants and sponsorships (with Novo Nordisk, Sanofi, Takeda, Kedrion Biopharma, HEMA Biologics, Pfizer, and CVS Health identified as financial partners), individual donations through the CHES Champions tiered program, and nominal event registration fees ($25/person with a $100 family cap). In January 2023, CHES merged with nSpiration Foundation to consolidate non-profit status. It is governed by a 7-member board of directors and operates with approximately 5 staff members, including co-founders Eric Lowe (COO) and Janet Brewer (Director Emerita).

Short descriptiontext

CHES Foundation is a 501(c)(3) non-profit founded in 2009 that delivers education, peer support, and advocacy programs to people affected by rare bleeding disorders in the United States, focusing on inhibitor, ultra-rare, and women's communities through conferences, camps, and digital content.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersNoblesville, United States
HQ citystring
Noblesville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
rare bleeding disorder education, nonprofit patient advocacy, inhibitor community support, rare disease conferences, bleeding disorder awareness campaigns
Industry3 codes
PRIMARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
SECONDARYBPAGACAC
Community Health, Prevention & Health Education
SECONDARYBPAGADAK
Youth Mental Health, Counseling & Wellbeing (Education-Linked) Nonprofits
Business & Public Services/Nonprofit, NGO & Social Services/Education & Youth Development Nonprofits
NAICS code1 code
  • Voluntary Health Organizations813212
SIC code1 code
  • Services-Misc Health & Allied Services, Nec8090
Product category
Rare Disease Patient Education and Advocacy
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Grant Funding
TypeAffiliate Referral
Description

CHES Foundation competes rigorously for grants provided by pharmaceutical manufacturers to support educational programming. The organization is a 501(c)3 nonprofit that fills gaps within patient communities through education, conference scholarships, and financial assistance.

ches.education
2Sponsorships
TypeAffiliate Referral
Description

Corporate sponsorships from pharmaceutical companies including Novo Nordisk, Sanofi, Takeda, Kedrion Biopharma, HEMA Biologics, Pfizer, CVS Health, and others fund specific programs and events.

ches.education
3Donations
TypeAffiliate Referral
Description

Tax-deductible donations through CHES Champions fund help cover travel costs for community members who would be unable to attend events without financial assistance.

ches.education
4Registration Fees
TypeSubscription Recurring
Description

Event registration fees of $25/person with cap of $100 for families implemented due to reduction in funding climate. Previously offered refundable deposits.

ches.education
Marketing channels11 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
Pricing details4 tiers
1Event Registration Fee
ModelUnit PricingBilling cadenceMulti-year contract
Notes

$25/person with cap of $100 for families over 4+ persons

ches.education
2Travel Reimbursement
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Mileage at $0.725/mile, air transportation arranged, meals provided on-site. Original itemized receipts required.

ches.education
3Registration Deposit
ModelSubscriptionBilling cadenceMulti-year contract
Notes

$25 per person deposit required upon application acceptance and booking travel for One Drop program.

ches.education
4CHES Champions Donation Tiers
ModelSubscriptionBilling cadenceMonthly
Notes

$50 covers one breakfast meal; $150 covers portion of educational costs; $250 covers child at hotel event; $500 covers lodging for one attendee/family for event weekend.

ches.education
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

CHES Foundation provides educational programs, peer support events, and awareness campaigns for individuals and families affected by rare bleeding disorders, particularly those with inhibitors, ultra-rare factor deficiencies, and women. The organization delivers national conferences (InhibitCon, LadyBugs, One Drop), family camps (After The Shock), adventure-based programs (Leverage), awareness campaigns (SHEmophilia, Hermanas de Sangre), webinars, the LifeLines for Health newsletter, and the Glanzmann Thrombasthenia Bleeding Edge podcast.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Developed 6 unique inhibitor-specific programs since 2010
+3 more records
Product overview1 text field

CHES Foundation operates as a non-profit organization offering educational programs and awareness campaigns for the rare bleeding disorder community. The core program portfolio includes InhibitCon (comprehensive inhibitor conference with Caregiver, Adult Men, and Teen tracks), After The Shock (family camp for inhibitor families), Leverage (adventure-based program for adults with inhibitors), LadyBugs (women's conference), One Drop (ultra-rare bleeding disorders program), and awareness campaigns SHEmophilia and Hermanas de Sangre. Supporting offerings include the LifeLines for Health newsletter and Bleeding Disorder News newsletter, along with the Glanzmann Thrombasthenia Bleeding Edge podcast series. Legacy programs Momentum, MUM, and Inhibitor Family Camp have been archived and integrated into current offerings. The organization competes for manufacturer grants to fund programming and is unaffiliated with any single product provider.

Product and service9 records
1InhibitCon
CategoryEducational Conference Program
Description

A comprehensive national conference for the inhibitor community featuring three distinct tracks (Caregiver, Adult Men, and Tweens/Teens), including camp-like activities and the Leverage program for adults 18+ with inhibitors. Designed for individuals with hemophilia A or B with inhibitors and their families.

2After The Shock
CategoryFamily Camp Program
Description

An inhibitor family camp experience welcoming all children ages 0-18 with an inhibitor, including infants and toddlers. Created in 2018 to replace the Inhibitor Family Camp with improved accommodations, providing a full family experience for inhibitor families.

3Leverage
CategoryAdventure Education Program
Description

An adventure-based program for adults 18+ with inhibitors, delivering experiential education activities in 24-hour or 5-day formats. Partners with GutMonkey for adventure activities designed for people with mobility, joint, muscle, and bleeding challenges.

4LadyBugs
CategoryWomen's Conference Program
Description

A national women's conference for women with bleeding disorders, caregivers, and carriers. Features educational sessions, peer support, and collaboration with state bleeding disorders foundations. 2026 venue: Colonial Williamsburg, VA.

5One Drop
CategoryUltra-Rare Disorders Program
Description

A program for individuals and families living with ultra-rare factor deficiencies (FI, FII, FV, FVII, FX, FXI, FXIII) and ultra-rare platelet deficiencies including Glanzmann's Thrombasthenia and Platelet Disorders. 2026 event: Tampa, FL Nov 13-15, 2026.

6SHEmophilia Campaign
CategoryAwareness Campaign
Description

A women with bleeding disorders awareness campaign featuring a documentary film series, podcast appearances, publications, and advocacy efforts including a Change.org petition to address healthcare inequities for women with bleeding disorders.

7Hermanas de Sangre Campaign
CategoryAwareness Campaign
Description

A Hispanic and Latina awareness campaign focusing on bleeding disorders education and advocacy for the Latino community through Spanish-language resources and culturally competent outreach.

8LifeLines for Health Newsletter
CategoryPublication
Description

A groundbreaking newsletter publication designed for topics relevant to those with inhibitors, serving as the only worldwide publication of its kind for the inhibitor community. Eric Lowe serves as editor, publisher, and designer.

9The Bleeding Edge Podcast
CategoryPodcast Series
Description

The first podcast series dedicated to exploring Glanzmann Thrombasthenia through voices of patients, caregivers, and clinicians across narrative-driven episodes.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2010-01-01
Description

Partnership with The Painted Turtle and Victory Junction (part of Paul Newman's Serious Fun Network) to host Inhibitor Family Camp since 2010, fostering life-long relationships and empowering families to advocate for themselves.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with GutMonkey for Leverage program - adventure-based experiential education for adults with inhibitors. Brings nearly two decades of experience in bleeding disorder camping and adventure education.

3Virginia Bleeding Disorders Foundation
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with Virginia Bleeding Disorders Foundation (formerly Virginia Hemophilia Foundation) for LadyBugs National Women's Conference 2026 in Colonial Williamsburg.

ches.education
4Girls Bleed Too
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Partnership with Girls Bleed Too for VWD webinar programming and women's health initiatives.

ches.education
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dr. Joanna Davis is member of ATHN. CHES collaborates with ATHN for research opportunities including ATHN Testing at One Drop event.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Janet Brewer served a two-year term on Novo Nordisk Consumer Council providing patient perspective.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

One Drop 2025 offered ATHN Testing Available for participants, providing genetic testing and research opportunities.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1National Hemophilia Foundation
TypeBroad incumbent
Description

The largest U.S. national nonprofit for bleeding disorders, providing education, advocacy, and research funding across hemophilia, von Willebrand disease, and other bleeding disorders. While not focused on CHES's specific inhibitor/ultra-rare/women niches, NHF is the dominant incumbent serving the same patient population.

2Hemophilia Federation of America
TypeBroad incumbent
Description

National nonprofit providing advocacy, education, and community programs across the bleeding disorders community. Former employer of CHES's Executive Director Heather Case; comparable mission and overlapping constituency but broader scope than CHES's inhibitor/ultra-rare/women focus.

3Hemophilia Alliance Foundation
TypeDirect peer
Description

Foundation supporting HTCs and bleeding disorder community programs through grants and innovation funding — including the 2023 Innovation Award given to CHES's SHEmophilia campaign. Directly comparable grantmaking peer within the same ecosystem.

TypeBroad incumbent
Description

International nonprofit focused on improving care for people with inherited bleeding disorders. Overlaps with CHES's mission at a global level, including the populations CHES serves (inhibitors, ultra-rare, and women's bleeding disorders).

5Coalition for Hemophilia B
TypeDirect peer
Description

National nonprofit dedicated to hemophilia B education, advocacy, and support. Smaller, disease-specific nonprofit similar in size and mission focus to CHES, with comparable dependence on pharmaceutical sponsorships.

TypeDirect peer
Description

Nonprofit providing direct financial assistance and program support to people with bleeding disorders in developing countries. Comparable nonprofit model with similar patient-education and direct-aid mission, although with international geographic focus.

7LA Kelley Communications
TypeEmerging player
Description

Independent publishing and patient education organization producing books, newsletters, and educational materials on hemophilia. Comparable focus on patient education content production within the bleeding disorders community.

8Girls Bleed Too
TypeOthers
Description

Research and data network supporting hemophilia treatment centers and patient outcomes research. Strategic partner with CHES for research opportunities at events like One Drop; functions as ecosystem infrastructure rather than direct competitor.

10Virginia Bleeding Disorders Foundation
TypeRegional player
Description

State-level bleeding disorders nonprofit and direct programmatic partner for CHES's LadyBugs 2026 conference. Regional peer with comparable patient-advocacy mission but geographically limited scope.

Market position
Weaknesses1 record

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CHES Foundation

Rare Disease Patient Education and Advocacycomphealthed.com

CHES Foundation is a 501(c)(3) non-profit founded in 2009 that delivers education, peer support, and advocacy programs to people affected by rare bleeding disorders in the United States, focusing on inhibitor, ultra-rare, and women's communities through conferences, camps, and digital content.

What CHES Foundation does

CHES Foundation is a 501(c)(3) non-profit organization founded in 2009 and headquartered in Noblesville, Indiana, that delivers education, peer support, and advocacy programs to the rare bleeding disorder community in the United States. The organization concentrates on three underserved populations: individuals with inhibitors (antibodies that neutralize standard clotting factor treatment), patients with ultra-rare bleeding disorders (including Glanzmann Thrombasthenia and rare factor deficiencies), and women with bleeding disorders. Its core program portfolio includes InhibitCon (a national inhibitor conference with caregiver, adult, and teen tracks), After The Shock (a family camp), Leverage (an adventure-based adult program delivered with GutMonkey), LadyBugs (a women's conference), One Drop (an ultra-rare disorders program), and awareness campaigns SHEmophilia and Hermanas de Sangre.

The organization's technology stack is intentionally lean and community-focused: a Squarespace-hosted website at ches.education, JotForm for application processing, Zoom for virtual programs, and active social media presence across Facebook, Instagram, LinkedIn, and YouTube. CHES produces proprietary content assets including the LifeLines for Health newsletter (described as the only worldwide publication dedicated to inhibitor topics) and The Bleeding Edge podcast (a narrative series on Glanzmann Thrombasthenia). Programs are delivered through a hybrid model combining national in-person events at hotels and camps with virtual webinars, supported by an application-based screening process and travel reimbursement for participants.

Revenue is generated primarily through pharmaceutical manufacturer grants and sponsorships (with Novo Nordisk, Sanofi, Takeda, Kedrion Biopharma, HEMA Biologics, Pfizer, and CVS Health identified as financial partners), individual donations through the CHES Champions tiered program, and nominal event registration fees ($25/person with a $100 family cap). In January 2023, CHES merged with nSpiration Foundation to consolidate non-profit status. It is governed by a 7-member board of directors and operates with approximately 5 staff members, including co-founders Eric Lowe (COO) and Janet Brewer (Director Emerita).

CHES Foundation firmographics

Firmographics
Name
CHES Foundation
Legal name
CHES Foundation, Inc.
Website
https://comphealthed.com
Company type
Private
Founded year
2009
Operating status
Operating
Short description
CHES Foundation is a 501(c)(3) non-profit founded in 2009 that delivers education, peer support, and advocacy programs to people affected by rare bleeding disorders in the United States, focusing on inhibitor, ultra-rare, and women's communities through conferences, camps, and digital content.
Ownership category
akta.pro rank

CHES Foundation industry classification

Industry
Product category
Rare Disease Patient Education and Advocacy
NAICS
Voluntary Health Organizations (813212)
SIC
Services-Misc Health & Allied Services, Nec (8090)
akta.pro industry
PRIMARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
SECONDARYBPAGACAC
Community Health, Prevention & Health Education
SECONDARYBPAGADAK
Youth Mental Health, Counseling & Wellbeing (Education-Linked) Nonprofits
Business & Public Services/Nonprofit, NGO & Social Services/Education & Youth Development Nonprofits

Keywords

  • Rare bleeding disorder education
  • Nonprofit patient advocacy
  • Inhibitor community support
  • Rare disease conferences
  • Bleeding disorder awareness campaigns

Where CHES Foundation is headquartered

Location

Headquarters

HQ city
Noblesville
HQ country
United States
HQ region
North America

Offices6 records

Markets served

CHES Foundation business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Grant Funding: CHES Foundation competes rigorously for grants provided by pharmaceutical manufacturers to support educational programming. The organization is a 501(c)3 nonprofit that fills gaps within patient communities through education, conference scholarships, and financial assistance.
  2. Sponsorships: Corporate sponsorships from pharmaceutical companies including Novo Nordisk, Sanofi, Takeda, Kedrion Biopharma, HEMA Biologics, Pfizer, CVS Health, and others fund specific programs and events.
  3. Donations: Tax-deductible donations through CHES Champions fund help cover travel costs for community members who would be unable to attend events without financial assistance.
  4. Registration Fees: Event registration fees of $25/person with cap of $100 for families implemented due to reduction in funding climate. Previously offered refundable deposits.

Pricing tiers

ModelBillingPrice
Unit PricingMulti-year contractEvent Registration Fee
SubscriptionPay-as-you-goTravel Reimbursement
SubscriptionMulti-year contractRegistration Deposit
SubscriptionMonthlyCHES Champions Donation Tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels11 records

CHES Foundation product offering

Product offering

Core offering

CHES Foundation provides educational programs, peer support events, and awareness campaigns for individuals and families affected by rare bleeding disorders, particularly those with inhibitors, ultra-rare factor deficiencies, and women. The organization delivers national conferences (InhibitCon, LadyBugs, One Drop), family camps (After The Shock), adventure-based programs (Leverage), awareness campaigns (SHEmophilia, Hermanas de Sangre), webinars, the LifeLines for Health newsletter, and the Glanzmann Thrombasthenia Bleeding Edge podcast.

Product overview

CHES Foundation operates as a non-profit organization offering educational programs and awareness campaigns for the rare bleeding disorder community. The core program portfolio includes InhibitCon (comprehensive inhibitor conference with Caregiver, Adult Men, and Teen tracks), After The Shock (family camp for inhibitor families), Leverage (adventure-based program for adults with inhibitors), LadyBugs (women's conference), One Drop (ultra-rare bleeding disorders program), and awareness campaigns SHEmophilia and Hermanas de Sangre. Supporting offerings include the LifeLines for Health newsletter and Bleeding Disorder News newsletter, along with the Glanzmann Thrombasthenia Bleeding Edge podcast series. Legacy programs Momentum, MUM, and Inhibitor Family Camp have been archived and integrated into current offerings. The organization competes for manufacturer grants to fund programming and is unaffiliated with any single product provider.

Differentiator

Problem solved

Functional benefit

Products and services

  • InhibitCon A comprehensive national conference for the inhibitor community featuring three distinct tracks (Caregiver, Adult Men, and Tweens/Teens), including camp-like activities and the Leverage program for adults 18+ with inhibitors. Designed for individuals with hemophilia A or B with inhibitors and their families.
  • After The Shock An inhibitor family camp experience welcoming all children ages 0-18 with an inhibitor, including infants and toddlers. Created in 2018 to replace the Inhibitor Family Camp with improved accommodations, providing a full family experience for inhibitor families.
  • Leverage An adventure-based program for adults 18+ with inhibitors, delivering experiential education activities in 24-hour or 5-day formats. Partners with GutMonkey for adventure activities designed for people with mobility, joint, muscle, and bleeding challenges.
  • LadyBugs A national women's conference for women with bleeding disorders, caregivers, and carriers. Features educational sessions, peer support, and collaboration with state bleeding disorders foundations. 2026 venue: Colonial Williamsburg, VA.
  • One Drop A program for individuals and families living with ultra-rare factor deficiencies (FI, FII, FV, FVII, FX, FXI, FXIII) and ultra-rare platelet deficiencies including Glanzmann's Thrombasthenia and Platelet Disorders. 2026 event: Tampa, FL Nov 13-15, 2026.
  • SHEmophilia Campaign A women with bleeding disorders awareness campaign featuring a documentary film series, podcast appearances, publications, and advocacy efforts including a Change.org petition to address healthcare inequities for women with bleeding disorders.
  • Hermanas de Sangre Campaign A Hispanic and Latina awareness campaign focusing on bleeding disorders education and advocacy for the Latino community through Spanish-language resources and culturally competent outreach.
  • LifeLines for Health Newsletter A groundbreaking newsletter publication designed for topics relevant to those with inhibitors, serving as the only worldwide publication of its kind for the inhibitor community. Eric Lowe serves as editor, publisher, and designer.
  • The Bleeding Edge Podcast The first podcast series dedicated to exploring Glanzmann Thrombasthenia through voices of patients, caregivers, and clinicians across narrative-driven episodes.

Quantifiable outcome

  • Developed 6 unique inhibitor-specific programs since 2010
  • +3 more outcomes

Companies that use CHES Foundation

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

CHES Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature2 records

CHES Foundation partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core, major and minor.

  • Serious Fun Network (The Painted Turtle and Victory Junction)coreStrategic or Co-development Partner · 1 January 2010Partnership with The Painted Turtle and Victory Junction (part of Paul Newman's Serious Fun Network) to host Inhibitor Family Camp since 2010, fostering life-long relationships and empowering families to advocate for themselves.
  • GutMonkeycoreStrategic or Co-development PartnerPartnership with GutMonkey for Leverage program - adventure-based experiential education for adults with inhibitors. Brings nearly two decades of experience in bleeding disorder camping and adventure education.
  • Virginia Bleeding Disorders FoundationcoreStrategic or Co-development PartnerPartnership with Virginia Bleeding Disorders Foundation (formerly Virginia Hemophilia Foundation) for LadyBugs National Women's Conference 2026 in Colonial Williamsburg.
  • Girls Bleed ToomajorStrategic or Co-development PartnerPartnership with Girls Bleed Too for VWD webinar programming and women's health initiatives.
  • ATHN (American Thrombosis and Hemostasis Network)coreStrategic or Co-development PartnerDr. Joanna Davis is member of ATHN. CHES collaborates with ATHN for research opportunities including ATHN Testing at One Drop event.
  • Novo Nordisk Consumer CouncilminorStrategic or Co-development PartnerJanet Brewer served a two-year term on Novo Nordisk Consumer Council providing patient perspective.
  • ATHN Testing InitiativemajorStrategic or Co-development PartnerOne Drop 2025 offered ATHN Testing Available for participants, providing genetic testing and research opportunities.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

CHES Foundation competitors and assessment

Company assessment

Broad incumbents

  • National Hemophilia Foundation: The largest U.S. national nonprofit for bleeding disorders, providing education, advocacy, and research funding across hemophilia, von Willebrand disease, and other bleeding disorders. While not focused on CHES's specific inhibitor/ultra-rare/women niches, NHF is the dominant incumbent serving the same patient population.
  • Hemophilia Federation of America: National nonprofit providing advocacy, education, and community programs across the bleeding disorders community. Former employer of CHES's Executive Director Heather Case; comparable mission and overlapping constituency but broader scope than CHES's inhibitor/ultra-rare/women focus.
  • World Federation of Hemophilia: International nonprofit focused on improving care for people with inherited bleeding disorders. Overlaps with CHES's mission at a global level, including the populations CHES serves (inhibitors, ultra-rare, and women's bleeding disorders).

Direct peers

  • Hemophilia Alliance Foundation: Foundation supporting HTCs and bleeding disorder community programs through grants and innovation funding — including the 2023 Innovation Award given to CHES's SHEmophilia campaign. Directly comparable grantmaking peer within the same ecosystem.
  • Coalition for Hemophilia B: National nonprofit dedicated to hemophilia B education, advocacy, and support. Smaller, disease-specific nonprofit similar in size and mission focus to CHES, with comparable dependence on pharmaceutical sponsorships.
  • Save One Life: Nonprofit providing direct financial assistance and program support to people with bleeding disorders in developing countries. Comparable nonprofit model with similar patient-education and direct-aid mission, although with international geographic focus.

Emerging players

  • LA Kelley Communications: Independent publishing and patient education organization producing books, newsletters, and educational materials on hemophilia. Comparable focus on patient education content production within the bleeding disorders community.

Peers

  • Girls Bleed Too:

Others

  • American Thrombosis and Hemostasis Network (ATHN): Research and data network supporting hemophilia treatment centers and patient outcomes research. Strategic partner with CHES for research opportunities at events like One Drop; functions as ecosystem infrastructure rather than direct competitor.

Regional players

  • Virginia Bleeding Disorders Foundation: State-level bleeding disorders nonprofit and direct programmatic partner for CHES's LadyBugs 2026 conference. Regional peer with comparable patient-advocacy mission but geographically limited scope.

Market position

Weaknesses1 record

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

CHES Foundation social profiles

Digital presence

CHES Foundation compliance and trust

Trust signal

Compliance3 records

CHES Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CHES Foundation leadership team

Management profile

Number of profiles

Profiles12 records

CHES Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CHES Foundation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CHES Foundation

What does CHES Foundation do?

CHES Foundation provides educational programs, peer support events, and awareness campaigns for individuals and families affected by rare bleeding disorders, particularly those with inhibitors, ultra-rare factor deficiencies, and women. The organization delivers national conferences (InhibitCon, LadyBugs, One Drop), family camps (After The Shock), adventure-based programs (Leverage), awareness campaigns (SHEmophilia, Hermanas de Sangre), webinars, the LifeLines for Health newsletter, and the Glanzmann Thrombasthenia Bleeding Edge podcast.

Is CHES Foundation a public or private company?

CHES Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was CHES Foundation founded?

CHES Foundation was founded in 2009.

Where is CHES Foundation based?

CHES Foundation is headquartered in Noblesville, United States, in the North America region.

How does CHES Foundation make money?

Four revenue lines are on record. Grant Funding is the primary driver. The others are sponsorships, donations and registration Fees.

Who are CHES Foundation's main competitors?

Broad incumbents on record are National Hemophilia Foundation, Hemophilia Federation of America and World Federation of Hemophilia. Direct peers are Hemophilia Alliance Foundation, Coalition for Hemophilia B and Save One Life. LA Kelley Communications is listed as an emerging player. Girls Bleed Too is listed as a peer. American Thrombosis and Hemostasis Network (ATHN) is listed as an others. Virginia Bleeding Disorders Foundation is listed as a regional player.

Does CHES Foundation have an API?

No public API is recorded for CHES Foundation.

What industry is CHES Foundation in?

CHES Foundation's product category is Rare Disease Patient Education and Advocacy. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS), with a secondary code of BPAGACAC, Community Health, Prevention & Health Education. Its NAICS code is 813212 and its SIC code is 8090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales